featured
Safety of Trastuzumab Deruxtecan With a Focus on Treatment-Related Interstitial Lung Disease and/or Pneumonitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The safety of trastuzumab deruxtecan (DS-8201) with a focus on interstitial lung disease and/or pneumonitis: A systematic review and single-arm meta-analysis
Cancer 2024 May 04;[EPub Ahead of Print], R Li, M Hua, J Li, W Chen, L Xu, H Meng, Z Zhang, Q Liu, Y Cui, Q XiangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.